Ecthymalike Ulcerations in Patients With Lung Cancer Treated With Combined Amivantamab and Osimertinib

JAMA Dermatology 2026

View at publisher
Authors: Stephen Li, Yoo Jung Kim, Esther Choi, Cuong V. Nguyen, Jennifer Nam Choi, Lida Zheng
DOI: 10.1001/jamadermatol.2026.1161
Cited by: 1
References: 6

Abstract

This case report describes 2 patients taking osimertinib and amivantamab who developed ecthymalike ulcerations refractory to tetracyclines and topical steroids.

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Colorectal Cancer Treatments and Studies Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Publication details

Journal / source
JAMA Dermatology
Publisher
American Medical Association (AMA)
Volume
162
Issue
7
Pages
756–756
Publication date
3 June 2026
Language
EN